CURE Pharmaceutical Announces Research Collaboration with CannaKids to Develop Cannabinoid and Terpene Molecules Using Cure’s Proprietary Delivery Technologies
March 06, 2017 16:15 ET
|
CURE Pharmaceutical
OXNARD, Calif., March 06, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”) or (the “Company”), a leading disruptive drug delivery technology company serving the pharmaceutical,...
CURE Pharmaceutical Welcomes Industry Veteran Richard Serbin to its Advisory Board
January 27, 2017 08:30 ET
|
CURE Pharmaceutical
OXNARD, Calif., Jan. 27, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC QB:CURR), a preeminent developer and manufacturer of advanced oral thin film for use in pharmaceutical, veterinary,...
CURE Pharmaceutical Moves to OTCQB Exchange
January 24, 2017 08:30 ET
|
CURE Pharmaceutical
OXNARD, Calif., Jan. 24, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC Pink:CURR), a preeminent developer and manufacturer of advanced oral thin film for use in pharmaceutical, veterinary,...
CURE Pharmaceutical Appoints William Yuan and Charles Berman to Its Board of Directors
December 22, 2016 08:30 ET
|
CURE Pharmaceutical
OXNARD, Calif., Dec. 22, 2016 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC Pink:CURR), a preeminent developer and manufacturer of advanced oral thin film for use in pharmaceutical, veterinary,...
Leading Developer of Multi-Layer Oral Thin Film CURE Pharmaceutical Completes Going Public Transaction; Company to Be Traded Using the Symbol CURR
December 20, 2016 08:30 ET
|
CURE Pharmaceutical
OXNARD, Calif., Dec. 20, 2016 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC Pink:CURR), a preeminent developer and manufacturer of advanced oral thin film for use in pharmaceutical, veterinary,...